Skip to main content
. 2022 Dec 29;15(1):197. doi: 10.3390/cancers15010197

Figure 1.

Figure 1

Building a predictive model for responsiveness to PD-1 inhibitors in NSCLC. (A) Comparison of the AUCs for the intrinsic gene signature according to six machine learning models. (B) Survival analysis according to the intrinsic gene signature. (C) Comparison of the AUCs for the extrinsic gene signature according to six machine learning models. (D) Survival analysis according to the extrinsic gene signature. (E) AUC according to PD-L1 expression. (F) Survival analysis according to PD-L1 expression. AUC, area under the ROC curve; NSCLC, non–small cell lung cancer; PD-1, programmed cell death protein 1; PD-L1, programmed cell death-ligand 1.